JP2016532645A5 - - Google Patents

Download PDF

Info

Publication number
JP2016532645A5
JP2016532645A5 JP2016520593A JP2016520593A JP2016532645A5 JP 2016532645 A5 JP2016532645 A5 JP 2016532645A5 JP 2016520593 A JP2016520593 A JP 2016520593A JP 2016520593 A JP2016520593 A JP 2016520593A JP 2016532645 A5 JP2016532645 A5 JP 2016532645A5
Authority
JP
Japan
Prior art keywords
delivery device
transdermal delivery
acid
dexmedetomidine
pain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016520593A
Other languages
English (en)
Japanese (ja)
Other versions
JP6188934B2 (ja
JP2016532645A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/059057 external-priority patent/WO2015054062A2/en
Publication of JP2016532645A publication Critical patent/JP2016532645A/ja
Publication of JP2016532645A5 publication Critical patent/JP2016532645A5/ja
Application granted granted Critical
Publication of JP6188934B2 publication Critical patent/JP6188934B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016520593A 2013-10-07 2014-10-03 デクスメデトミジン経皮組成物を含む疼痛管理用方法及び組成物 Active JP6188934B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361887870P 2013-10-07 2013-10-07
US61/887,870 2013-10-07
PCT/US2014/059057 WO2015054062A2 (en) 2013-10-07 2014-10-03 Methods and compositions for managing pain comprising dexmedetomidine transdermal compositions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017146472A Division JP6522062B2 (ja) 2013-10-07 2017-07-28 デクスメデトミジン経皮組成物を含む疼痛管理用方法及び組成物

Publications (3)

Publication Number Publication Date
JP2016532645A JP2016532645A (ja) 2016-10-20
JP2016532645A5 true JP2016532645A5 (cg-RX-API-DMAC7.html) 2017-07-06
JP6188934B2 JP6188934B2 (ja) 2017-08-30

Family

ID=52777129

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016520593A Active JP6188934B2 (ja) 2013-10-07 2014-10-03 デクスメデトミジン経皮組成物を含む疼痛管理用方法及び組成物
JP2017146472A Active JP6522062B2 (ja) 2013-10-07 2017-07-28 デクスメデトミジン経皮組成物を含む疼痛管理用方法及び組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017146472A Active JP6522062B2 (ja) 2013-10-07 2017-07-28 デクスメデトミジン経皮組成物を含む疼痛管理用方法及び組成物

Country Status (10)

Country Link
US (2) US20150098982A1 (cg-RX-API-DMAC7.html)
EP (1) EP3054931B1 (cg-RX-API-DMAC7.html)
JP (2) JP6188934B2 (cg-RX-API-DMAC7.html)
KR (2) KR101891186B1 (cg-RX-API-DMAC7.html)
CN (2) CN105764495A (cg-RX-API-DMAC7.html)
CA (1) CA2924188C (cg-RX-API-DMAC7.html)
ES (1) ES2855103T3 (cg-RX-API-DMAC7.html)
RU (1) RU2654702C2 (cg-RX-API-DMAC7.html)
TW (1) TWI629061B (cg-RX-API-DMAC7.html)
WO (1) WO2015054062A2 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101891185B1 (ko) 2013-10-07 2018-08-24 테이코쿠 팔마 유에스에이, 인코포레이티드 비진정량의 덱스메데토미딘의 경피 전달을 위한 방법 및 조성물
TWI709417B (zh) 2013-10-07 2020-11-11 美商帝國製藥美國股份有限公司 使用右美托咪啶經皮組成物用於治療注意力不足過動症、焦慮及失眠的方法及組成物
RU2646512C2 (ru) 2013-10-07 2018-03-05 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Устройства для трансдермальной доставки дексмедетомидина и способы их применения
CN105764495A (zh) * 2013-10-07 2016-07-13 帝国制药美国公司 用于管理疼痛的包含右旋美托咪啶经皮组合物的方法及组合物
KR20190060007A (ko) 2016-10-31 2019-05-31 테이코쿠 팔마 유에스에이, 인코포레이티드 덱스메데토미딘 경피 전달 장치를 이용한 통증을 관리하는 방법
IL267689B2 (en) 2016-12-31 2025-05-01 Bioxcel Therapeutics Inc Use of sublingual dexmedetomidine for the treatment of agitation
IL279713B2 (en) 2018-06-27 2025-01-01 Bioxcel Therapeutics Inc Dexmedetomidine-containing layer compositions and methods for their production
US12472158B2 (en) 2019-02-27 2025-11-18 Vanderbilt University Methods of treating trigeminal nerve pain
KR20220002950A (ko) 2019-05-01 2022-01-07 클렉시오 바이오사이언시스 리미티드 소양증의 치료 방법
WO2020222192A1 (en) 2019-05-01 2020-11-05 Clexio Biosciences Ltd. Methods of treating pruritus
EP3999058A4 (en) 2019-07-19 2023-05-03 Bioxcel Therapeutics, Inc. TREATMENT SCHEMES FOR NON-SEDATING DEXMEDETOMIDIN
WO2024037545A1 (zh) * 2022-08-17 2024-02-22 宜昌人福药业有限责任公司 右美托咪定经皮组合物、透皮贴剂及其制备方法和应用
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
GB9111732D0 (en) * 1991-05-31 1991-07-24 Orion Yhtymae Oy The use of certain salts of medetomidine and its optically active enantiomers to regulate the rate of transdermal administration of the drugs
GB2290964A (en) * 1994-07-08 1996-01-17 Arto Olavi Urtti Transdermal drug delivery system
PL181582B1 (pl) * 1995-06-07 2001-08-31 Ortho Mcneil Pharm Inc Plaster na skóre do zapobiegania owulacji u kobiety oraz plaster na skóre do przeprowadzania hormonalnej terapii substytucyjnej PL PL PL PL PL PL PL PL
ES2228125T3 (es) * 1998-10-02 2005-04-01 3M Innovative Properties Company Sistemas de suministro de farmacos originados en las mucosas.
US7635488B2 (en) * 2001-03-13 2009-12-22 Dbv Technologies Patches and uses thereof
KR100511492B1 (ko) * 2002-10-11 2005-08-31 주식회사 태평양 에페리손, 톨페리손 또는 그것들의 염을 포함하는경피흡수제제
EP1652508B1 (en) * 2003-07-31 2013-12-04 Hisamitsu Pharmaceutical Co., Inc. Adhesive patch
EP1663311A2 (en) * 2003-09-12 2006-06-07 Allergan, Inc. Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
KR101042490B1 (ko) * 2004-07-15 2011-06-16 니뽄 다바코 산교 가부시키가이샤 축합 벤즈아미드 화합물 및 바닐로이드 수용체 1형(vr1)활성 저해제
US20070134310A1 (en) * 2005-09-23 2007-06-14 Nedberge Diane E Transdermal risperidone delivery system
EP2308480B1 (en) * 2005-09-23 2014-08-13 ALZA Corporation High Enhancer-Loading Polyacrylate Formulation for Transdermal Applications
JP4148988B2 (ja) * 2006-09-11 2008-09-10 積水化学工業株式会社 貼付剤
US8889173B2 (en) * 2008-04-18 2014-11-18 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
JP5547065B2 (ja) * 2008-05-15 2014-07-09 久光製薬株式会社 パロノセトロンを含有する経皮吸収製剤
WO2010014076A1 (en) * 2008-07-28 2010-02-04 EndogenX, Inc. Methods to treat pain using an alpha-2 adrenergic agonist and an endothelin antagonist
US9308203B2 (en) * 2008-10-01 2016-04-12 Taiwan Biotech Co., Ltd. Pressure sensitive adhesive matrix device or system for the treatment or prevention of onychomycosis or tinea pedis
US20130072532A1 (en) * 2010-01-08 2013-03-21 Recro Pharma, Inc. Topical transdermal dexmedetomidine compositions and methods of use thereof
US8563031B2 (en) * 2010-05-27 2013-10-22 Absize, Inc. Piroxicam-containing matrix patches and methods for the topical treatment of acute and chronic pain and inflammation therewith
CA2815898C (en) * 2010-11-17 2018-12-18 Hexal Ag Transdermal therapeutic system comprising buprenorphine
US20130096170A1 (en) * 2011-10-14 2013-04-18 Hospira, Inc. Methods of treating pediatric patients using dexmedetomidine
CN105764495A (zh) * 2013-10-07 2016-07-13 帝国制药美国公司 用于管理疼痛的包含右旋美托咪啶经皮组合物的方法及组合物

Similar Documents

Publication Publication Date Title
JP2016532643A5 (cg-RX-API-DMAC7.html)
JP2016532641A5 (cg-RX-API-DMAC7.html)
JP2016532644A5 (cg-RX-API-DMAC7.html)
FI3054934T3 (fi) Menetelmät ja koostumukset vieroitusoireyhtymien hoitoon käyttäen ei-sedatiivisia transdermaalisia deksmedetomidiinikoostumuksia
RU2018105761A (ru) Устройства для трансдермальной доставки дексмедетомидина и способы их применения
JP6522062B2 (ja) デクスメデトミジン経皮組成物を含む疼痛管理用方法及び組成物
JP6188933B2 (ja) 非鎮静量のデクスメデトミジンの経皮送達用方法及び組成物
EP3939661B1 (en) Patch
JPWO2019142940A1 (ja) 皮膚貼付用粘着シート
JP6324964B2 (ja) 貼付剤
ES2629063T3 (es) Preparación de parche
JP2016532642A5 (cg-RX-API-DMAC7.html)
WO2021157457A1 (ja) ブロナンセリン含有貼付剤、及びその製造方法
JP7045045B2 (ja) 外用剤
US20170224630A1 (en) Patch
JP5623102B2 (ja) セレギリン含有貼付製剤
JP7683987B2 (ja) ブロナンセリン含有貼付剤、及びその製造方法
JP2021506783A (ja) 経皮薬物送達の間にデポを作成するための方法
JP2023531918A5 (cg-RX-API-DMAC7.html)
JP5930877B2 (ja) 経皮吸収製剤
WO2012017892A1 (ja) 貼付剤及びその粘着力増強方法
KR102279552B1 (ko) 부토르파놀 함유 첩부제
WO2021137102A1 (en) Octenidine salt antimicrobial medical articles
CN118317769A (zh) 贴剂
WO2023100740A1 (ja) 貼付剤